(D-HIS2)-TRIPTORELIN is a synthetic peptide analog of gonadotropin-releasing hormone (GnRH) that functions as a potent agonist at the GnRH receptor. It is specifically designed to treat hormone-dependent conditions by modulating the hormonal balance in the body.
Used in Pharmaceutical Industry:
(D-HIS2)-TRIPTORELIN is used as a therapeutic agent for the treatment of hormone-dependent conditions such as prostate cancer, endometriosis, and precocious puberty. It operates by continuously stimulating the GnRH receptor, which results in the suppression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) production. This suppression leads to a decrease in the synthesis of testosterone and estrogen, thereby helping to slow the growth of hormone-dependent tumors and alleviate symptoms associated with hormone imbalances.
Used in Oncology:
In the field of oncology, (D-HIS2)-TRIPTORELIN is used as an anti-cancer agent, particularly for the treatment of prostate cancer. Its mechanism of action involves the downregulation of testosterone production, which is often a driving factor in the progression of prostate cancer. By reducing testosterone levels, (D-HIS2)-TRIPTORELIN can help control tumor growth and improve patient outcomes.
Used in Endocrinology:
(D-HIS2)-TRIPTORELIN is also used in endocrinology for the management of endometriosis, a condition where tissue similar to the lining of the uterus grows outside the uterus. By decreasing the levels of estrogen, which plays a role in the growth of endometrial tissue, (D-HIS2)-TRIPTORELIN can help reduce the symptoms and progression of endometriosis.
Used in Pediatric Endocrinology:
For pediatric endocrinology, (D-HIS2)-TRIPTORELIN is utilized in the treatment of precocious puberty, a condition where puberty begins before the age of 8 in girls and 9 in boys. By suppressing the production of hormones responsible for puberty, (D-HIS2)-TRIPTORELIN can delay the onset of sexual maturation, allowing for normal growth and development.
(D-HIS2)-TRIPTORELIN is typically administered via injection and is known for its long-lasting effect, making it a convenient and effective treatment option for the conditions it addresses.
Used in Pharmaceutical Industry:
(D-HIS2)-TRIPTORELIN is used as a therapeutic agent for the treatment of hormone-dependent conditions such as prostate cancer, endometriosis, and precocious puberty. It operates by continuously stimulating the GnRH receptor, which results in the suppression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) production. This suppression leads to a decrease in the synthesis of testosterone and estrogen, thereby helping to slow the growth of hormone-dependent tumors and alleviate symptoms associated with hormone imbalances.
Used in Oncology:
In the field of oncology, (D-HIS2)-TRIPTORELIN is used as an anti-cancer agent, particularly for the treatment of prostate cancer. Its mechanism of action involves the downregulation of testosterone production, which is often a driving factor in the progression of prostate cancer. By reducing testosterone levels, (D-HIS2)-TRIPTORELIN can help control tumor growth and improve patient outcomes.
Used in Endocrinology:
(D-HIS2)-TRIPTORELIN is also used in endocrinology for the management of endometriosis, a condition where tissue similar to the lining of the uterus grows outside the uterus. By decreasing the levels of estrogen, which plays a role in the growth of endometrial tissue, (D-HIS2)-TRIPTORELIN can help reduce the symptoms and progression of endometriosis.
Used in Pediatric Endocrinology:
For pediatric endocrinology, (D-HIS2)-TRIPTORELIN is utilized in the treatment of precocious puberty, a condition where puberty begins before the age of 8 in girls and 9 in boys. By suppressing the production of hormones responsible for puberty, (D-HIS2)-TRIPTORELIN can delay the onset of sexual maturation, allowing for normal growth and development.
(D-HIS2)-TRIPTORELIN is typically administered via injection and is known for its long-lasting effect, making it a convenient and effective treatment option for the conditions it addresses.
321709-34-6
Post Buying Request-
-
Basic information
- Product Name: (D-HIS2)-TRIPTORELIN
- Synonyms: PYR-D-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2;(D-HIS2)-TRIPTORELIN;(D-HIS2,D-TRP6)-GONADOTROPIN-RELEASING HORMONE;(D-HIS2,D-TRP6)-LHRH;(D-HIS2,D-TRP6)-LUTEINIZING HORMONE-RELEASING FACTOR;(D-HIS2,D-TRP6)-LUTEINIZING HORMONE-RELEASING HORMONE;(D-His2,D-Trp6)-LHRH (D-His2)-Triptorelin
- CAS NO:321709-34-6
- Molecular Formula: C64H82N18O13
- Molecular Weight: 1311.45
- EINECS: N/A
- Product Categories: N/A
- Mol File: 321709-34-6.mol
-
Chemical Properties
- Melting Point: N/A
- Boiling Point: N/A
- Flash Point: N/A
- Appearance: /
- Density: 1.52±0.1 g/cm3(Predicted)
- Refractive Index: N/A
- Storage Temp.: -15°C
- Solubility: N/A
- PKA: 9.82±0.15(Predicted)
- CAS DataBase Reference: (D-HIS2)-TRIPTORELIN(CAS DataBase Reference)
- NIST Chemistry Reference: (D-HIS2)-TRIPTORELIN(321709-34-6)
- EPA Substance Registry System: (D-HIS2)-TRIPTORELIN(321709-34-6)
-
Safety Data
- Hazard Codes: N/A
- Statements: N/A
- Safety Statements: N/A
- WGK Germany:
- RTECS:
- HazardClass: N/A
- PackingGroup: N/A
- Hazardous Substances Data: 321709-34-6(Hazardous Substances Data)
321709-34-6 Suppliers
Recommended suppliers
321709-34-6 Usage
Check Digit Verification of cas no
The CAS Registry Mumber 321709-34-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,1,7,0 and 9 respectively; the second part has 2 digits, 3 and 4 respectively.Calculate Digit Verification of CAS Registry Number 321709-34:
(8*3)+(7*2)+(6*1)+(5*7)+(4*0)+(3*9)+(2*3)+(1*4)=116
116 % 10 = 6
So 321709-34-6 is a valid CAS Registry Number.
321709-34-6Upstream product
321709-34-6Downstream Products
Post a RFQ
1
What can I do for you?
Get Best Price
Get Best Price for 321709-34-6
(D-HIS2)-TRIPTORELIN
